Immunology
1 drug is in development for Chronic Granulomatous Disease.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Chronic Granulomatous Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| pm359 | Prime Medicine, Inc. (PRME) |
About this indication
Chronic Granulomatous Disease context
Immunology·MeSH: Granulomatous Disease, Chronic (D006105)
Also known as: Chronic Granulomatous Diseases
Frequently asked questions
How many drugs are in development for Chronic Granulomatous Disease?
BioSniper tracks 1 drug in development for Chronic Granulomatous Disease across 1 company.
How many clinical trials target Chronic Granulomatous Disease?
There are 6 clinical trials targeting Chronic Granulomatous Disease tracked by BioSniper.